APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mecobalamin API

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Mecobalamin API Market Outlook and Growth Opportunities 2026

23 December 2025196 pages

Choose your research edition.

Industry ResearchMecobalamin API Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Mecobalamin API Industry Growth and Trends Forecast to 2032105 pages · $3,450 USDMarket StructureGlobal Mecobalamin API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mecobalamin API Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Mecobalamin API Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Mecobalamin API market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Mecobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Mecobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mecobalamin API is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Mecobalamin API market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Mecobalamin API market include Yufeng Industry Group, Yabao Pharmaceutical, Eisai, E-CSPC, Novartis, Ningxia Kingvit Pharmaceutical, Merck, HTBA and EUROAPI, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Mecobalamin API market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mecobalamin API and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mecobalamin API sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Mecobalamin API market size, projected growth trends, production technologies, key applications, and end-use industries.

Mecobalamin API Segment by Company

Yufeng Industry Group

Yabao Pharmaceutical

Eisai

E-CSPC

Novartis

Ningxia Kingvit Pharmaceutical

Merck

HTBA

EUROAPI

Atom Pharma

Mecobalamin API Segment by Type

Purity≥99%

Purity<99%

Mecobalamin API Segment by Application

Injectable Formulation

Sprays

Oral Formulation

Mecobalamin API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mecobalamin API status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Mecobalamin API market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mecobalamin API significant trends, drivers, influence factors in global and regions.

6. To analyze Mecobalamin API competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mecobalamin API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mecobalamin API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mecobalamin API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Mecobalamin API market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mecobalamin API industry.

Chapter 3: Detailed analysis of Mecobalamin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Mecobalamin API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Mecobalamin API in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mecobalamin API Industry Trends Table 2. Mecobalamin API Industry Drivers Table 3. Mecobalamin API Industry Opportunities and Challenges Table 4. Mecobalamin API Industry Restraints Table 5. Global Mecobalamin API Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mecobalamin API Revenue Share by Company (2021-2026) Table 7. Global Mecobalamin API Sales Volume by Company (kg) & (2021-2026) Table 8. Global Mecobalamin API Sales Volume Share by Company (2021-2026) Table 9. Global Mecobalamin API Average Price (USD/g) of Company (2021-2026) Table 10. Global Mecobalamin API Company Ranking, (2024-2026) & (USD Million) Table 11. Global Mecobalamin API Key Company Manufacturing Base & Headquarters Table 12. Global Mecobalamin API Company, Product Type & Application Table 13. Global Mecobalamin API Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Mecobalamin API by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity≥99% Table 18. Significant Companies of Purity<99% Table 19. Global Mecobalamin API Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Mecobalamin API Sales Volume by Type (2021-2026) & (kg) Table 21. Global Mecobalamin API Sales Volume by Type (2027-2032) & (kg) Table 22. Global Mecobalamin API Sales Volume Share by Type (2021-2026) Table 23. Global Mecobalamin API Sales Volume Share by Type (2027-2032) Table 24. Global Mecobalamin API Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Mecobalamin API Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Mecobalamin API Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Mecobalamin API Sales Value Share by Type (2021-2026) Table 28. Global Mecobalamin API Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Injectable Formulation Table 30. Significant Companies of Sprays Table 31. Significant Companies of Oral Formulation Table 32. Global Mecobalamin API Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 33. Global Mecobalamin API Sales Volume by Application (2021-2026) & (kg) Table 34. Global Mecobalamin API Sales Volume by Application (2027-2032) & (kg) Table 35. Global Mecobalamin API Sales Volume Share by Application (2021-2026) Table 36. Global Mecobalamin API Sales Volume Share by Application (2027-2032) Table 37. Global Mecobalamin API Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Mecobalamin API Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Mecobalamin API Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Mecobalamin API Sales Value Share by Application (2021-2026) Table 41. Global Mecobalamin API Sales Value Share by Application (2027-2032) Table 42. Global Mecobalamin API Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 43. Global Mecobalamin API Sales by Region (2021-2026) & (kg) Table 44. Global Mecobalamin API Sales Market Share by Region (2021-2026) Table 45. Global Mecobalamin API Sales by Region (2027-2032) & (kg) Table 46. Global Mecobalamin API Sales Market Share by Region (2027-2032) Table 47. Global Mecobalamin API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Mecobalamin API Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Mecobalamin API Sales Value Share by Region (2021-2026) Table 50. Global Mecobalamin API Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Mecobalamin API Sales Value Share by Region (2027-2032) Table 52. Global Mecobalamin API Market Average Price (USD/g) by Region (2021-2026) Table 53. Global Mecobalamin API Market Average Price (USD/g) by Region (2027-2032) Table 54. Global Mecobalamin API Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 55. Global Mecobalamin API Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Mecobalamin API Sales by Country (2021-2026) & (kg) Table 57. Global Mecobalamin API Sales Market Share by Country (2021-2026) Table 58. Global Mecobalamin API Sales by Country (2027-2032) & (kg) Table 59. Global Mecobalamin API Sales Market Share by Country (2027-2032) Table 60. Global Mecobalamin API Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Mecobalamin API Sales Value Market Share by Country (2021-2026) Table 62. Global Mecobalamin API Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Mecobalamin API Sales Value Market Share by Country (2027-2032) Table 64. Yufeng Industry Group Company Information Table 65. Yufeng Industry Group Business Overview Table 66. Yufeng Industry Group Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 67. Yufeng Industry Group Mecobalamin API Product Portfolio Table 68. Yufeng Industry Group Recent Development Table 69. Yabao Pharmaceutical Company Information Table 70. Yabao Pharmaceutical Business Overview Table 71. Yabao Pharmaceutical Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 72. Yabao Pharmaceutical Mecobalamin API Product Portfolio Table 73. Yabao Pharmaceutical Recent Development Table 74. Eisai Company Information Table 75. Eisai Business Overview Table 76. Eisai Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 77. Eisai Mecobalamin API Product Portfolio Table 78. Eisai Recent Development Table 79. E-CSPC Company Information Table 80. E-CSPC Business Overview Table 81. E-CSPC Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 82. E-CSPC Mecobalamin API Product Portfolio Table 83. E-CSPC Recent Development Table 84. Novartis Company Information Table 85. Novartis Business Overview Table 86. Novartis Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 87. Novartis Mecobalamin API Product Portfolio Table 88. Novartis Recent Development Table 89. Ningxia Kingvit Pharmaceutical Company Information Table 90. Ningxia Kingvit Pharmaceutical Business Overview Table 91. Ningxia Kingvit Pharmaceutical Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 92. Ningxia Kingvit Pharmaceutical Mecobalamin API Product Portfolio Table 93. Ningxia Kingvit Pharmaceutical Recent Development Table 94. Merck Company Information Table 95. Merck Business Overview Table 96. Merck Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 97. Merck Mecobalamin API Product Portfolio Table 98. Merck Recent Development Table 99. HTBA Company Information Table 100. HTBA Business Overview Table 101. HTBA Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 102. HTBA Mecobalamin API Product Portfolio Table 103. HTBA Recent Development Table 104. EUROAPI Company Information Table 105. EUROAPI Business Overview Table 106. EUROAPI Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 107. EUROAPI Mecobalamin API Product Portfolio Table 108. EUROAPI Recent Development Table 109. Atom Pharma Company Information Table 110. Atom Pharma Business Overview Table 111. Atom Pharma Mecobalamin API Sales (kg), Value (US$ Million), Price (USD/g) and Gross Margin (2021-2026) Table 112. Atom Pharma Mecobalamin API Product Portfolio Table 113. Atom Pharma Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Mecobalamin API Distributors List Table 117. Mecobalamin API Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Mecobalamin API Product Image Figure 2. Global Mecobalamin API Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mecobalamin API Sales Value (2021-2032) & (US$ Million) Figure 4. Global Mecobalamin API Sales (2021-2032) & (kg) Figure 5. Global Mecobalamin API Sales Average Price (USD/g) & (2021-2032) Figure 6. Global Mecobalamin API Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity≥99% Image Figure 10. Purity<99% Image Figure 11. Global Mecobalamin API Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Mecobalamin API Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Mecobalamin API Sales Volume Share by Type (2021-2032) Figure 14. Global Mecobalamin API Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Mecobalamin API Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Mecobalamin API Sales Value Share by Type (2021-2032) Figure 17. Injectable Formulation Image Figure 18. Sprays Image Figure 19. Oral Formulation Image Figure 20. Global Mecobalamin API Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 21. Global Mecobalamin API Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Mecobalamin API Sales Volume Share by Application (2021-2032) Figure 23. Global Mecobalamin API Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Mecobalamin API Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Mecobalamin API Sales Value Share by Application (2021-2032) Figure 26. Global Mecobalamin API Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 27. Global Mecobalamin API Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Mecobalamin API Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Mecobalamin API Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Mecobalamin API Sales Value (2021-2032) & (US$ Million) Figure 31. North America Mecobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Mecobalamin API Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Mecobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Mecobalamin API Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Mecobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Mecobalamin API Sales Value (2021-2032) & (US$ Million) Figure 37. South America Mecobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Mecobalamin API Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Mecobalamin API Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Mecobalamin API Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Mecobalamin API Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Mecobalamin API Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Mecobalamin API Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Mecobalamin API Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Purity≥99%
  • Purity<99%
Applications
  • Injectable Formulation
  • Sprays
  • Oral Formulation
Companies covered
  • Yufeng Industry Group
  • Yabao Pharmaceutical
  • Eisai
  • E-CSPC
  • Novartis
  • Ningxia Kingvit Pharmaceutical
  • Merck
  • HTBA
  • EUROAPI
  • Atom Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mecobalamin API Sales Value (2021-2032)
  4. 1.2.2 Global Mecobalamin API Sales Volume (2021-2032)
  5. 1.2.3 Global Mecobalamin API Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Mecobalamin API Market Dynamics
  1. 2.1 Mecobalamin API Industry Trends
  2. 2.2 Mecobalamin API Industry Drivers
  3. 2.3 Mecobalamin API Industry Opportunities and Challenges
  4. 2.4 Mecobalamin API Industry Restraints
3 Mecobalamin API Market by Company
  1. 3.1 Global Mecobalamin API Company Revenue Ranking in 2025
  2. 3.2 Global Mecobalamin API Revenue by Company (2021-2026)
  3. 3.3 Global Mecobalamin API Sales Volume by Company (2021-2026)
  4. 3.4 Global Mecobalamin API Average Price by Company (2021-2026)
  5. 3.5 Global Mecobalamin API Company Ranking (2024-2026)
  6. 3.6 Global Mecobalamin API Company Manufacturing Base and Headquarters
  7. 3.7 Global Mecobalamin API Company Product Type and Application
  8. 3.8 Global Mecobalamin API Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Mecobalamin API Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Mecobalamin API Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Mecobalamin API Market by Type
  1. 4.1 Mecobalamin API Type Introduction
  2. 4.1.1 Purity≥99%
  3. 4.1.2 Purity<99%
  4. 4.2 Global Mecobalamin API Sales Volume by Type
  5. 4.2.1 Global Mecobalamin API Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Mecobalamin API Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Mecobalamin API Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Mecobalamin API Sales Value by Type
  9. 4.3.1 Global Mecobalamin API Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Mecobalamin API Sales Value by Type (2021-2032)
  11. 4.3.3 Global Mecobalamin API Sales Value Share by Type (2021-2032)
5 Mecobalamin API Market by Application
  1. 5.1 Mecobalamin API Application Introduction
  2. 5.1.1 Injectable Formulation
  3. 5.1.2 Sprays
  4. 5.1.3 Oral Formulation
  5. 5.2 Global Mecobalamin API Sales Volume by Application
  6. 5.2.1 Global Mecobalamin API Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mecobalamin API Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Mecobalamin API Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Mecobalamin API Sales Value by Application
  10. 5.3.1 Global Mecobalamin API Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Mecobalamin API Sales Value by Application (2021-2032)
  12. 5.3.3 Global Mecobalamin API Sales Value Share by Application (2021-2032)
6 Mecobalamin API Regional Sales and Value Analysis
  1. 6.1 Global Mecobalamin API Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mecobalamin API Sales by Region (2021-2032)
  3. 6.2.1 Global Mecobalamin API Sales by Region: 2021-2026
  4. 6.2.2 Global Mecobalamin API Sales by Region (2027-2032)
  5. 6.3 Global Mecobalamin API Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Mecobalamin API Sales Value by Region (2021-2032)
  7. 6.4.1 Global Mecobalamin API Sales Value by Region: 2021-2026
  8. 6.4.2 Global Mecobalamin API Sales Value by Region (2027-2032)
  9. 6.5 Global Mecobalamin API Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Mecobalamin API Sales Value (2021-2032)
  12. 6.6.2 North America Mecobalamin API Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Mecobalamin API Sales Value (2021-2032)
  15. 6.7.2 Europe Mecobalamin API Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Mecobalamin API Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Mecobalamin API Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Mecobalamin API Sales Value (2021-2032)
  21. 6.9.2 South America Mecobalamin API Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Mecobalamin API Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Mecobalamin API Sales Value Share by Country, 2025 VS 2032
7 Mecobalamin API Country-level Sales and Value Analysis
  1. 7.1 Global Mecobalamin API Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mecobalamin API Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Mecobalamin API Sales by Country (2021-2032)
  4. 7.3.1 Global Mecobalamin API Sales by Country (2021-2026)
  5. 7.3.2 Global Mecobalamin API Sales by Country (2027-2032)
  6. 7.4 Global Mecobalamin API Sales Value by Country (2021-2032)
  7. 7.4.1 Global Mecobalamin API Sales Value by Country (2021-2026)
  8. 7.4.2 Global Mecobalamin API Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Mecobalamin API Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Mecobalamin API Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Mecobalamin API Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Mecobalamin API Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Mecobalamin API Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Mecobalamin API Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Mecobalamin API Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Mecobalamin API Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Mecobalamin API Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Mecobalamin API Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Mecobalamin API Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Mecobalamin API Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Mecobalamin API Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Mecobalamin API Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Mecobalamin API Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Mecobalamin API Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Mecobalamin API Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Mecobalamin API Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Mecobalamin API Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Mecobalamin API Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Mecobalamin API Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Mecobalamin API Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Mecobalamin API Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Mecobalamin API Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Mecobalamin API Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Mecobalamin API Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Mecobalamin API Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Mecobalamin API Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Mecobalamin API Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Mecobalamin API Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Mecobalamin API Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Yufeng Industry Group
  2. 8.1.1 Yufeng Industry Group Company Information
  3. 8.1.2 Yufeng Industry Group Business Overview
  4. 8.1.3 Yufeng Industry Group Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Yufeng Industry Group Mecobalamin API Product Portfolio
  6. 8.1.5 Yufeng Industry Group Recent Developments
  7. 8.2 Yabao Pharmaceutical
  8. 8.2.1 Yabao Pharmaceutical Company Information
  9. 8.2.2 Yabao Pharmaceutical Business Overview
  10. 8.2.3 Yabao Pharmaceutical Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Yabao Pharmaceutical Mecobalamin API Product Portfolio
  12. 8.2.5 Yabao Pharmaceutical Recent Developments
  13. 8.3 Eisai
  14. 8.3.1 Eisai Company Information
  15. 8.3.2 Eisai Business Overview
  16. 8.3.3 Eisai Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Eisai Mecobalamin API Product Portfolio
  18. 8.3.5 Eisai Recent Developments
  19. 8.4 E-CSPC
  20. 8.4.1 E-CSPC Company Information
  21. 8.4.2 E-CSPC Business Overview
  22. 8.4.3 E-CSPC Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 E-CSPC Mecobalamin API Product Portfolio
  24. 8.4.5 E-CSPC Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novartis Mecobalamin API Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Ningxia Kingvit Pharmaceutical
  32. 8.6.1 Ningxia Kingvit Pharmaceutical Company Information
  33. 8.6.2 Ningxia Kingvit Pharmaceutical Business Overview
  34. 8.6.3 Ningxia Kingvit Pharmaceutical Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Ningxia Kingvit Pharmaceutical Mecobalamin API Product Portfolio
  36. 8.6.5 Ningxia Kingvit Pharmaceutical Recent Developments
  37. 8.7 Merck
  38. 8.7.1 Merck Company Information
  39. 8.7.2 Merck Business Overview
  40. 8.7.3 Merck Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Merck Mecobalamin API Product Portfolio
  42. 8.7.5 Merck Recent Developments
  43. 8.8 HTBA
  44. 8.8.1 HTBA Company Information
  45. 8.8.2 HTBA Business Overview
  46. 8.8.3 HTBA Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 HTBA Mecobalamin API Product Portfolio
  48. 8.8.5 HTBA Recent Developments
  49. 8.9 EUROAPI
  50. 8.9.1 EUROAPI Company Information
  51. 8.9.2 EUROAPI Business Overview
  52. 8.9.3 EUROAPI Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 EUROAPI Mecobalamin API Product Portfolio
  54. 8.9.5 EUROAPI Recent Developments
  55. 8.10 Atom Pharma
  56. 8.10.1 Atom Pharma Company Information
  57. 8.10.2 Atom Pharma Business Overview
  58. 8.10.3 Atom Pharma Mecobalamin API Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Atom Pharma Mecobalamin API Product Portfolio
  60. 8.10.5 Atom Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Mecobalamin API Value Chain Analysis
  2. 9.1.1 Mecobalamin API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Mecobalamin API Sales Mode & Process
  6. 9.2 Mecobalamin API Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Mecobalamin API Distributors
  9. 9.2.3 Mecobalamin API Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst